KLAS Contact
Contact KLAS
Contact KLAS
2022 BEST IN KLAS
Preferences
Related Series
2022
2018
2017
2016
2015
2013
2012
2011
2010
2008
2007
Related Segments
Related Products
Related Vendors
Related Articles
Smart Pump/EMR Interoperability 2020
First Look at Customer Satisfaction
Author
Jackson Tate
Author
Paul Warburton
Current Time Inside Cache Tag Helper: 5/26/2022 11:22:06 PM and Model.reportId = 1500
For the first time, adoption of bidirectional smart pump/EMR interoperability is high enough that KLAS can examine customer satisfaction—at least among BD and ICU Medical users on the pump side and Cerner and Epic customers on the EMR side. How well do these four vendors support their customers’ pump/EMR interoperability efforts? Are specific vendor combinations more likely to achieve success? In addition, this report examines what progress (if any) other pump and EMR vendors have made with interoperability development and adoption.if you don't have a login, getting started is easy.
Key Findings:
- Pump Vendors: Support & Guidance
- ICU Medical Delivers Strong Guidance at All Stages; BD Has Adoption Momentum, Struggles with Ongoing Optimization
- Interoperable vs. Noninteroperable Customers
- EMR Vendors: Interoperability Development
- Cerner Workflows More Streamlined; Both Cerner and Epic Could Improve Reporting & Timeliness of Updates
- Which EMRs Are Being Integrated?
- Which Pump/EMR Combos Are Most Successful?
- ICU Medical/Epic, BD/Cerner Customers Most Satisfied
- Status of Bidirectional Smart Pump/EMR Interoperability
- Technology Is Only Half the Story
- Vendor Bottom Lines
Writer
Elizabeth Pew
Project Manager
Mary Brown
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.